#75 Strong Clinical Relevance
High-quality evidence with meaningful patient or clinical significance.
Clinicians need to counsel male patients that cannabis use may impair sperm quality and increase their partner’s miscarriage risk, representing a modifiable preconception risk factor that affects reproductive outcomes for couples planning pregnancy. This finding expands the clinical importance of cannabis screening beyond individual patient health to include reproductive health counseling for men of childbearing age. Patients attempting conception should understand that cannabis use by male partners carries potential consequences for pregnancy success, making this relevant information for both obstetric and primary care settings.
Recent evidence suggests that paternal cannabis use may significantly increase miscarriage risk in female partners, potentially doubling the likelihood of pregnancy loss through effects on sperm quality and function. Studies examining cannabis’s impact on male reproductive health have documented alterations in sperm parameters and increased DNA damage that could compromise early pregnancy viability when transmitted to the developing embryo. This finding adds to growing concerns about cannabis’s broader health effects, including associations with increased cancer risk and accelerated aging, making reproductive toxicity an important consideration in preconception counseling. Clinicians should be aware that paternal cannabis exposure represents a modifiable risk factor that warrants discussion during fertility consultations and pregnancy planning conversations, particularly for couples with a history of recurrent miscarriage. While research in this area continues to evolve, the current evidence suggests counseling male patients who use cannabis about potential reproductive risks when conception is planned or being considered.
“When a man uses cannabis regularly, we’re seeing evidence that it may compromise sperm quality in ways that increase miscarriage risk for his partner, which means this isn’t just a personal health decision anymore—it’s a reproductive health conversation I need to have with male patients who are planning pregnancies or in relationships where conception is possible.”
💊 While emerging evidence suggests cannabis use may impair male fertility and potentially increase miscarriage risk through effects on sperm quality, clinicians should recognize that this literature remains preliminary and causality has not been definitively established. The mechanisms proposed—including oxidative stress and epigenetic changes in sperm—are plausible but require validation in larger, prospective human studies that account for confounders such as partner age, alcohol use, overall health status, and other lifestyle factors. Current cannabis potency, frequency of use, and route of administration vary widely and may influence reproductive outcomes differently, yet most clinical studies lack granular exposure data. When counseling couples about modifiable risk factors for miscarriage and infertility, healthcare providers may reasonably discuss cannabis cessation as part of comprehensive preconception optimization for both partners, while acknowledging the limited strength of current evidence and avoiding overstated claims that could diminish trust in clinical guidance.
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
FAQ
This News item was assembled from structured source metadata and pipeline scoring.
Have thoughts on this? Share it:
